Vericel is dedicated to the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions.
REPORT RATINGS
4.8 / 5.0 (129)
Vericel Corp reports have an aggregate usefulness score of 4.8 based on 129 reviews.